384
Views
16
CrossRef citations to date
0
Altmetric
Articles

Factors associated with delayed presentation at the emergency department in patients with acute ischemic stroke

ORCID Icon, , , , , , , , & show all
Pages 1257-1261 | Received 18 Nov 2018, Accepted 04 Jul 2019, Published online: 11 Jul 2019

References

  • WHO Estimates for 2000–2012. WHO.
  • Ramani L, Huang X, Cheripelli B, Muir KW. Intravenous thrombolysis for acute stroke: current standards and future directions. Curr Treat Options Cardiovasc Med. 2015;17:1–14. doi:10.1007/s11936-015-0373-2.
  • The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–87. doi:10.1056/NEJM199512143332401.
  • Hacke W, Kaste M, Fieschi C, Toni D, Lasaffre E, von Kummer R, Boysen G, Bluhmki E, Höxter G, Mahagne MH. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017–25.
  • Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian acute stroke study investigators. Lancet (London, England). 1998;352:1245–51.
  • Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase thrombolysis for acute noninterventional therapy in ischemic stroke. JAMA. 1999;282:2019–26. doi:10.1001/jama.282.21.2019.
  • Fisher M, Ringleb PA, Schellinger PD, Schranz C, Hacke W. Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful? Stroke. 2002;33:1437–41.
  • Evenson KR, Foraker RE, Morris DL, Rosamond WD. A comprehensive review of prehospital and in-hospital delay times in acute stroke care. Int J Stroke. 2009;4:187–99. doi:10.1111/j.1747-4949.2009.00276.x.
  • Rossnagel K, Jungehülsing GJ, Nolte CH, Müller-Nordhorn J, Roll S, Wegscheider K, Villringer A, Willich SN. Out-of-hospital delays in patients with acute stroke. Ann Emerg Med. 2004;44:476–83. doi:10.1016/S0196064404000939.
  • Agyeman O, Nedeltchev K, Arnold M, Fischer U, Remonda L, Isenegger J, Schroth G, Mattle HP. Time to admission in acute ischemic stroke and transient ischemic attack. Stroke. 2006;37:963–66. doi:10.1161/01.STR.0000206546.76860.6b.
  • Boode B, Welzen V, Franke C, van Oostenbrugge R. Estimating the number of stroke patients eligible for thrombolytic treatment if delay could be avoided. Cerebrovasc Dis. 2007;23:294–98. doi:10.1159/000098330.
  • van Den Berg JSP, de Jong G. Why ischemic stroke patients do not receive thrombolytic treatment: results from a general hospital. Acta Neurol Scand. 2009;120:157–60. doi:10.1111/j.1600-0404.2008.01140.x.
  • Addo J, Ayis S, Leon J, Rudd AG, McKevitt C, Wolfe CDA. Delay in presentation after an acute stroke in a multiethnic population in South London: the South London stroke register. J Am Heart Assoc. 2012;1:e001685. doi:10.1161/JAHA.112.001685.
  • Hagiwara Y, Imai T, Yamada K, Sakurai K, Atsumi C, Tsuruoka A, Mizukami H, Sasaki N, Akiyama H, Hasegawa Y. Impact of life and family background on delayed presentation to hospital in acute stroke. J Stroke Cerebrovasc Dis. 2014;23:625–29. doi:10.1016/j.jstrokecerebrovasdis.2013.05.034.
  • Harraf F, Sharma AK, Brown MM, Lees KR, Vass RI, Karla L. A multicentre observational study of presentation and early assessment of acute stroke. BMJ. 2002;325:17. doi:10.1136/bmj.325.7354.17.
  • Morris DL, Rosamond W, Madden K, Schlutz C, Hamilton S. Prehospital and emergency department delays after acute stroke: the Genentech Stroke Presentation Survey. Stroke. 2000;31:2585–90.
  • Lacy CR, Suh D-C, Bueno M, Kostis JB. Delay in presentation and evaluation for acute stroke : Stroke Time Registry for Outcomes Knowledge and Epidemiology (S.T.R.O.K.E.). Stroke. 2001;32:63–69. doi:10.1161/01.STR.32.1.63.
  • Iosif C, Papathanasiou M, Staboulis E, Gouliamos A. Social factors influencing hospital arrival time in acute ischemic stroke patients. Neuroradiology. 2012;54:361–67. doi:10.1007/s00234-011-0884-9.
  • Papapanagiotou P, Iacovidou N, Spengos K, Xanthos T, Zaganas I, Aggelina A, Alegakis A, Vemmos K. Temporal trends and associated factors for pre-hospital and in-hospital delays of stroke patients over a 16-year period: the Athens study. Cerebrovasc Dis. 2011;31:199–206. doi:10.1159/000321737.
  • Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18. [accessed 2017 Mar 24]. http://clinchem.aaccjnls.org/content/18/6/499.long
  • Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130:461–70. doi:10.7326/0003-4819-130-8-199904200-00013.
  • Wester P, Radberg J, Lundgren B, Peltonen N. Factors associated with delayed admission to hospital and in-hospital delays in acute stroke and TIA: a prospective, multicenter study. Seek- medical-attention-in-time study group. Stroke. 1999;30:40–48. doi:10.1161/01.STR.30.1.40.
  • Derex L, Adeleine P, Nighoghossian N, Honnorat J, Trouillas P. Factors influencing early admission in a French stroke unit. Stroke. 2002;33:153–59.
  • Jin H, Zhu S, Wei JW, Wang J, Liu M, Wu Y, Wong LKS, Cheng Y, Xu E, Yang Q, et al. Factors associated with prehospital delays in the presentation of acute stroke in urban China. Stroke. 2012;43:362–70.
  • O’Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang X, Pais P, Agapay S, Lopez-Jaramilo P, Damasceno A. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388:761–75. doi:10.1016/S0140-6736(16)30506-2.
  • Hatzitolios AI, Spanou M, Dambali R, Vraka K, Doumarapis E, Petratos K, Savopoulos C, Tziomalos K. Public awareness of stroke symptoms and risk factors and response to acute stroke in Northern Greece. Int J Stroke. 2014;9:E15–E15. doi:10.1111/ijs.12261.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.